The healthcare company has posted a loss in the wake of a failed stock offer.
The Public Investment Corporation, South Africa’s biggest stock investor, says local ownership is key for growing the economy and empowering people.
The drawn-out battle for Adcock now sees CFR’s offer for Adcock now facing resistance from the PIC, which says the offer is not up to scratch.
A day after putting in an offer to acquire part of Adcock Ingram, Bidvest is taking the company to court over an "unlawful" guarantee.
Drugmaker Adcock Ingram says the $1.2-billion takeover bid from CFR Pharmaceuticals is still the best option, despite Bidvest’s offer.
A Chilean group’s $1.2-billion bid for Adcock Ingram has been challenged by a court action from Bidvest.
Bidvest has put in a R4-billion offer for pharmaceuticals company Adcock, countering that of Chilean company CFR Pharmaceuticals.
Chile’s largest drugmaker will decide within weeks whether to make a binding offer for Adcock Ingram Holdings.
Adcock Ingram has entered into discussions with a Chile-based firm, which could see SA benefit from a possible combined revenue of R12.1-billion.